RecruitingNot ApplicableNCT03199651

Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

Beating Lung Cancer in Ohio (BLCIO) Protocol


Sponsor

Ohio State University Comprehensive Cancer Center

Enrollment

3,584 participants

Start Date

Jul 17, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized clinical trial studies the Beating Lung Cancer in Ohio protocol in improving survival in patients with stage IV non-small cell lung cancer. The Beating Lung Cancer in Ohio protocol may help in evaluating immunotherapies and targeted therapies that prolong survival, have more favorable toxicity profiles than conventional chemotherapy and impact quality of life.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial studies ways to improve survival and quality of care for people with advanced (stage IV) non-small cell lung cancer in Ohio, including support for smokers in the household. You may be eligible if... - You have been confirmed to have stage IV non-small cell lung cancer (any type) - You speak English and are willing to share medical records and answer questionnaires - You are enrolled preferably before starting treatment or within one month of starting therapy - For the smoking part: you are a current or recent smoker (quit less than 3 months ago) with a household member who also smokes You may NOT be eligible if... - You are being treated with surgery or definitive chemoradiotherapy - You have been receiving treatment for advanced lung cancer for more than one month before enrolling - You have vision or hearing problems that prevent you from completing the study requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBest Practice

Receive usual care

PROCEDUREBiospecimen Collection

Undergo collection of tumor tissue and blood sample for repository

PROCEDUREBiospecimen Collection

Undergo tumor tissue and blood sample for AGIT/DS

OTHERLaboratory Biomarker Analysis

Correlative studies

OTHERMedical Chart Review

Undergo medical record abstraction

OTHERQuality-of-Life Assessment

Ancillary studies

OTHERQuestionnaire Administration

Ancillary studies

BEHAVIORALSmoking Cessation Intervention

Undergo usual care or NCCN-driven CTC/DS


Locations(1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03199651


Related Trials